Sprague-Dawley (SD) Rat Mesenchymal Stem Cells with GFP

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C1312
Description
Mesenchymal stem cells with GFP (MSCs/GFP) are multipotent stem cells that can differentiate into a variety of cell types including osteocytes, adipocytes, and chondrocytes. MSCs/GFP proliferate quickly and are capable of generating a local immunosuppressive microenvironment, thus contributing to their wide application potentials in tissue engineering, cell therapy, and gene therapy. Sprague-Dawley (SD)Rat Mesenchymal Stem Cells are derived from the bone marrow of Sprague-Dawley (SD) Rats, cultured as monolayer, and then have been transfected with a lentiviral construct containing a GFP expression motif.
Species
Rat
Recommended Medium
Rat Mesenchymal Stem Cell Growth Medium
Application
For Research Use Only
Shipping
Dry Ice
Quality Control
Sterility, Safety, HIV/viruses, bacteria, fungi: negative.
Storage and Shipping
Remove cryovials (dry ice packaging) and place the vial into liquid nitrogen for storage. Alternatively, thaw and use the cells immediately.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Sprague-Dawley (SD) Rat Mesenchymal Stem Cells with GFP are primary bone marrow-derived mesenchymal stem cells (BMSCs) obtained from the femur/tibia of healthy SD rats and stably transduced with a lentiviral vector encoding Green Fluorescent Protein (GFP) for real-time fluorescence tracking. These cells show typical MSC features namely, spindle shaped adherent growth, fibroblast-like form, expression of mesenchymal surface markers (CD29, CD44, and CD90 >70%) and lack of hematopoietic surface markers (CD34, CD45, and CD11b <5%), and the ability to differentiate in vitro into osteoblasts, adipocytes, and chondrocytes in vitro. These are usually cultivated in a basal nutritional medium supplemented with serum and growth factors, under standard conditions (37 °C, 5% CO₂) at a recommended seeding density of 2-4 × 10⁴ cells/cm², and passaged before over-confluence to maintain multipotency (limited to ~5-10 passages).

The integrated GFP reporter enables immediate visualization of cell survival, migration and homing following in vivo transplantation without further labeling. Thus, these GFP-labeled SD rat MSCs are widely used in the preclinical field to study cell tracking, engraftment efficiency, immunomodulatory, and paracrine effects in various rat disease models, including orthotopic bone/cartilage repair, spinal cord or myocardial infarction models, and so on.

RSP Recruits Endogenous Mesenchymal Stem Cells to Rat Ischemic Hindlimbs

Mesenchymal stem cell (MSC)-based therapies face limitations in critical limb ischemia (CLI) due to poor sustainability. Park et al. evaluated whether a substance P-conjugated scaffold (RSP) could enhance angiogenesis by improving MSC retention and recruitment.

Immunohistochemistry (IHC) tracked MSCs in rat ischemic hindlimbs at 7, 14, and 28 days (Fig. 1). In the MSC-only group, GFP-labeled exogenous cells (green) co-localized with MSC markers (CD105, CD90, CD29; red). The RSP-only group lacked GFP signal but showed persistent endogenous MSC recruitment (red) up to 28 days. In the MSC + RSP group, merged imaging revealed both exogenous MSCs (yellow, co-localization of red and green) and recruited endogenous MSCs (red only). The control group showed no positive staining for any MSC markers. These results demonstrate that RSP sustains exogenous MSC delivery while simultaneously recruiting endogenous MSCs to the ischemic site, independent of ischemia-induced recruitment alone.

Fluorescent immunohistochemical staining for stem cell markers (A) CD105, (B) CD90, and (C) CD29 from ischemic hindlimbs injected with rat MSC (tagged with green fluorescent protein), RSP, and a combination of MSC and RSP (10× magnification).

Fig. 1. Fluorescent immunohistochemical staining for stem cell markers (A) CD105, (B) CD90, and (C) CD29 from ischemic hindlimbs injected with rat MSC (tagged with green fluorescent protein), RSP, and a combination of MSC and RSP (10× magnification) (Park H S, Choi G H, et al., 2024).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products